Outcome of kidney transplantation for XXXX :a single-center experience.

@entity1 @entity12042 @entity827 @entity2783 @entity309
The aim of this retrospective study was to investigate the results of kidney transplantation in @entity1 with @entity12042 . We analyzed the results of renal transplantation in 13 amyloidotic transplant recipients compared with those in a control group of 13 nonamyloidotic @entity1 . While the etiology of @entity2783 was @entity309 in one @entity1 , in all of the others it was secondary to @entity827 . Acute rejection episodes developed once in six and twice in one @entity1 . The renal function in these @entity1 was improved by antirejection treatment. Chronic rejection did not develop in any @entity1 . However six @entity1 (46%) died due to various complications despite functional grafts. The others are still being followed with well-functioning grafts. Among the control group, acute and chronic rejection were diagnosed in three and two @entity1 , respectively: one @entity1 returned to hemodialysis after 26 months of transplantation, while the others are still alive with functional grafts. There was no death in the control group. The 5- and 10-year actuarial @entity1 survival rates of the @entity2783 and control groups were 52.2%, 26.6%, and 100%, 100%, respectively (P = .002). However, the graft survivals of the @entity2783 versus control groups were 100%, 100%, versus 87.5%, 87.5, respectively (P = .47). In conclusion, we observed a high rate of early mortality among recipients with @entity2783 associated with infectious complications. Moreover, @entity1 survivals were lower among amyloidotic renal recipients.
